Smoking Completed Phase 2 Trials for TA-NIC (DB05445)

IndicationStatusPhase
DBCOND0027935 (Smoking)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00633321Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking CessationTreatment